Together, the results of this study demonstrate that BMP6 treatment is a potent inducer of mineralization via an endochondral-like pathway in neonatal mammalian basicranial-derived cells in vitro, while standard OM is ineffective in stimulating mineralization. The gene discussed is BMP6; the disease is ocular melanoma.